Reliq Health Technologies Announces New Paid Pilots in Maryland, Illinois, Montana, New Jersey and Florida

Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) solutions for the community-based healthcare market, is pleased to announce that it has signed paid pilot agreements with new clients in five states to conduct 30-90 day trials of Reliq’s iUGO Care remote patient monitoring, telemedicine and chronic care management platform.

“As part of our strategy to diversify our client base and expand our footprint in the US, we are pleased to announce that Reliq has signed paid pilot agreements with five new clients across five states,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.  “Not only are we expanding into states where we have not previously had a presence, we are serving more diverse clinical populations.  These pilots will use iUGO Care to improve health outcomes and reduce the cost of care for patients with a broad range of clinical conditions including COPD, sleep apnea, chronic wounds, diabetes, hypertension and congestive heart failure.  Historically our value proposition in the US has centered around patients covered by Medicaid, a state-run program based on financial need.  The changes CMS announced in 2019 for remote patient monitoring and telehealth reimbursement have substantially increased our total addressable market to include Medicare patients in all fifty states.  We’re very excited to be working with new clients in Florida, Maryland, New Jersey, Montana and Illinois as well as our existing clients in Texas, Indiana, Canada and Australia.”

The paid pilots are expected to go live beginning in Q2, 2019.  As part of the pilot agreements, each client has agreed to issue a joint news release with the Company as soon as their individual pilot goes live.  The clients include a large employer health plan, the home health services division of a state-wide health system, a pulmonary medicine center, a home health agency that serves 11 counties and a community health system that includes an acute care hospital and several senior living communities.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

ABOUT RELIQ HEALTH

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market.  Reliq’s powerful iUGO Care platform supports remote patient monitoring, chronic care management, telemedicine and wound care. The Company’s software solutions allow complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

For further information please contact:

Investor Relations at ir@reliqhealth.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future plans, programs, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development and the potential benefits of, and demand for, our products and services.

We caution you that such forward-looking statements involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.  These risks and uncertainties include, among other things, risks inherent to technology development, the development of the market for our products and services, and our ability to execute on our marketing and business plans.  Actual results may differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements are provided to assist readers in understanding management’s expectations for the business as at the date of this release, and may not be suitable for other purposes.

Reliq Health Technologies Inc. (the “Company”) does not intend, and does not assume any obligation, to update these forward-looking statements except as expressly required by law.